怀孕中的免疫编辑:理解胎儿耐受性和产科疾病的新范式
Muhammad Adrianes Bachnas1, Wiku Andonotopo2, Julian Dewantiningrum3
1Department of Obstetrics and Gynecology, Fetomaternal Division, Medical Faculty of Sebelas Maret University, Dr. Moewardi Hospital, Surakarta, Indonesia.
Journal of perinatal medicine
|March 12, 2026
概括
怀孕涉及复杂的免疫调节,而不是抑制. 应用癌症免疫编辑概念可以澄清母胎耐受性和产科疾病,提供新的治疗途径.
科学领域:
- 生殖免疫学 生殖免疫学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 怀孕呈现出一种免疫学悖论:母亲对半异质胎儿的免疫耐受性.
- 孕期是一个动态的,调节的免疫状态,而不是免疫抑制.
研究的目的:
- 将癌症免疫编辑框架 (消除,平衡,逃脱) 应用于母胎免疫耐受性.
- 通过整合瘤学和生殖免疫学,为妊娠免疫调节提供统一的概念.
主要方法:
- 审查将癌症免疫编辑框架应用于生殖免疫学.
- 检查免疫检查点,调节性T细胞,MHC分子和胎盘外体的免疫耐受性.
主要成果:
- 免疫编辑框架为母胎免疫耐受性提供了新的视角.
- 关键的免疫组件,如检查点,Tregs,和外体组编排一个局部耐受环境.
结论:
- 产科疾病 (孕前,流产,早产) 可能代表不同免疫阶段的失败.
- 这一框架表明了怀孕护理诊断和治疗方面的潜在临床进展.
相关概念视频
Development of Immunocompetence
1.1K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Special Features of Adaptive Immunity
3.9K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
3.9K
Teratogenicity
4.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Transcytosis of IgG
4.4K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.4K
CRISPR
58.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.6K
RNA Editing
10.1K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
10.1K


